- Home
- WIX vs BMRN Comparison
WIX vs BMRN Comparison
Compare WIX & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIX
- BMRN
- Stock Information
- Founded
- WIX 2006
- BMRN 1996
- Country
- WIX Israel
- BMRN United States
- Employees
- WIX N/A
- BMRN N/A
- Industry
- WIX Computer Software: Programming Data Processing
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- WIX Technology
- BMRN Health Care
- Exchange
- WIX Nasdaq
- BMRN Nasdaq
- Market Cap
- WIX 12.1B
- BMRN 13.7B
- IPO Year
- WIX 2013
- BMRN 1999
- Fundamental
- Price
- WIX $165.87
- BMRN $68.32
- Analyst Decision
- WIX Strong Buy
- BMRN Buy
- Analyst Count
- WIX 17
- BMRN 22
- Target Price
- WIX $246.24
- BMRN $94.00
- AVG Volume (30 Days)
- WIX 858.2K
- BMRN 1.4M
- Earning Date
- WIX 05-19-2025
- BMRN 04-23-2025
- Dividend Yield
- WIX N/A
- BMRN N/A
- EPS Growth
- WIX 314.03
- BMRN 153.71
- EPS
- WIX 2.36
- BMRN 2.21
- Revenue
- WIX $1,760,650,000.00
- BMRN $2,853,915,000.00
- Revenue This Year
- WIX $14.56
- BMRN $12.23
- Revenue Next Year
- WIX $13.29
- BMRN $9.90
- P/E Ratio
- WIX $69.49
- BMRN $30.84
- Revenue Growth
- WIX 12.74
- BMRN 17.97
- 52 Week Low
- WIX $117.58
- BMRN $60.63
- 52 Week High
- WIX $247.11
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- WIX 35.94
- BMRN 42.46
- Support Level
- WIX $159.25
- BMRN $69.60
- Resistance Level
- WIX $175.83
- BMRN $73.18
- Average True Range (ATR)
- WIX 6.30
- BMRN 1.80
- MACD
- WIX 0.86
- BMRN -0.56
- Stochastic Oscillator
- WIX 34.56
- BMRN 14.89
About WIX Wix.com Ltd.
Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.